A 2-Year-Old Child with Alazami Syndrome with Newly Reported Findings of Immune Deficiency, Periventricular Nodular Heterotopia, and Stroke; Broadening the Phenotype of Alazami
dc.contributor.author | Fauntleroy-Love, Kristin D. | |
dc.contributor.author | Wilson, Theodore E. | |
dc.contributor.author | Padem, Nurcicek | |
dc.contributor.author | Golomb, Meredith R. | |
dc.contributor.department | Pediatrics, School of Medicine | |
dc.date.accessioned | 2024-03-01T14:00:56Z | |
dc.date.available | 2024-03-01T14:00:56Z | |
dc.date.issued | 2023-07-27 | |
dc.description.abstract | Alazami syndrome is a rare autosomal recessive neurodevelopmental disorder due to loss-of-function variants in the La ribonucleoprotein 7 (LARP7) gene. Children with Alazami syndrome are most often affected by a combination of primordial dwarfism, intellectual disability, and distinctive facial features. Previous cases have been primarily found in consanguineous families from the Middle East, Asia, and North Africa. We present a 21-month-old Caucasian male from the Midwest United States with nonconsanguineous parents who presented with frequently reported findings of unusual facial features, poor growth, cardiac and genitourinary findings, and developmental delay; less-frequently reported findings, including transient erythroblastopenia of childhood (TEC) and immune deficiency; and never-before reported findings of periventricular nodular heterotopia and stroke. He developed stroke during a hospitalization for Hemophilus influenzae meningitis. The possible contributions of LARP7 to TEC, immune deficiency, brain malformation, and stroke are discussed. Guidelines for the care of Alazami patients are proposed. | |
dc.eprint.version | Final published version | |
dc.identifier.citation | Fauntleroy-Love KD, Wilson TE, Padem N, Golomb MR. A 2-Year-Old Child with Alazami Syndrome with Newly Reported Findings of Immune Deficiency, Periventricular Nodular Heterotopia, and Stroke; Broadening the Phenotype of Alazami. Child Neurol Open. 2023;10:2329048X231190784. Published 2023 Jul 27. doi:10.1177/2329048X231190784 | |
dc.identifier.uri | https://hdl.handle.net/1805/38998 | |
dc.language.iso | en_US | |
dc.publisher | Sage | |
dc.relation.isversionof | 10.1177/2329048X231190784 | |
dc.relation.journal | Child Neurology Open | |
dc.rights | Attribution-NonCommercial 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.source | PMC | |
dc.subject | Alazami syndrome | |
dc.subject | LARP7 | |
dc.subject | Developmental disabilities | |
dc.subject | Immune deficiency | |
dc.subject | Intellectual disability | |
dc.subject | Periventricular nodular heterotopia | |
dc.subject | Primordial dwarfism | |
dc.subject | Stroke | |
dc.subject | Transient erythroblastemia of childhood | |
dc.title | A 2-Year-Old Child with Alazami Syndrome with Newly Reported Findings of Immune Deficiency, Periventricular Nodular Heterotopia, and Stroke; Broadening the Phenotype of Alazami | |
dc.type | Article |